2001
DOI: 10.1007/pl00007462
|View full text |Cite
|
Sign up to set email alerts
|

The efficacy of retroviral herpes simplex virus thymidine kinase gene transfer and ganciclovir treatment on the inhibition of melanoma growth in vitro and in vivo

Abstract: One approach to gene therapy of cancer is based on the insertion of a suicide gene into tumor cells and subsequent activation of the suicide mechanism. We used the herpes simplex virus thymidine kinase (HSVtk) gene followed by ganciclovir (GCV) treatment. The goal of our experiments was to determine the effectiveness of HSVtk gene therapy in malignant melanoma. B16BL6 murine melanoma cells retrovirally transduced with the HSVtk gene became sensitive to low concentrations of GCV. Analysis by RT-PCR showed HSVtk… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…Classical cancer suicide gene therapy employs genes encoding enzymes that convert non‐toxic prodrugs into cytotoxic compounds (5). However, these prodrug systems have been assayed in melanoma both in vitro and in vivo with limited results (6,7). As an attractive alternative to this strategy, therapeutic genes that directly encode cytotoxic proteins could be used.…”
Section: Introductionmentioning
confidence: 99%
“…Classical cancer suicide gene therapy employs genes encoding enzymes that convert non‐toxic prodrugs into cytotoxic compounds (5). However, these prodrug systems have been assayed in melanoma both in vitro and in vivo with limited results (6,7). As an attractive alternative to this strategy, therapeutic genes that directly encode cytotoxic proteins could be used.…”
Section: Introductionmentioning
confidence: 99%